Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Monoaxial vs. Polyaxial Hybrid Stabilization for Thoracolumbar Fractures in Older Adults

Official title: Monoaxial vs. Polyaxial Percutaneous Hybrid Stabilization for Thoracolumbar Fractures in Elderly Patients: A Randomized, Single-Blind Pilot Study

Run by Medical University Innsbruck · NCT07408726 · Data updated 2026-11-12

This study tests whether monoaxial pedicle screws provide better alignment and stability than polyaxial screws in older adults with thoracolumbar fractures treated with a percutaneous hybrid stabilization technique.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment44 (estimated)
SponsorMedical University Innsbruck
Academic / other
Drugs / interventionschemotherapy, immunotherapy, radiation, prednisone
Locations1 site (Innsbruck, Tyrol)
StatusRecruiting
StartedSeptember 1, 2026
Main results expectedSeptember 1, 2028
Study endsNovember 1, 2028
Registry record updatedOctober 9, 2026
Trial IDNCT07408726 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 60 and older with acute thoracolumbar fractures between T11 and L4 suitable for percutaneous bisegmental hybrid stabilization.

Probably not a fit

Patients with fractures outside the specified range, non-suitable morphology, or contraindications to cement augmentation or percutaneous techniques may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial compares two screw designs—monoaxial and polyaxial—used in percutaneous bisegmental hybrid stabilization with cement-augmented pedicle screws and balloon kyphoplasty for thoracolumbar fractures in patients aged 60 and older. It seeks to determine differences in radiographic alignment, kyphosis correction, and clinical outcomes between the two approaches. Eligible participants have acute fractures between T11 and L4 and are suitable for this minimally invasive stabilization method. The study is conducted at a single center with experienced spinal surgeons and follows patients longitudinally to assess early mobilization, deformity correction, and functional recovery. Primary and secondary outcomes focus on radiographic measures and patient-reported outcomes over follow-up visits.

Why it matters

Potential benefit: If successful, patients may achieve better spinal alignment and stability after surgery, with potential improvements in mobility and quality of life.

How similar studies have gone: Prior use of cement-augmented percutaneous hybrid stabilization is established, but direct comparison of monoaxial versus polyaxial screws in this context is less well defined.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patient-related criteria:

1. Age ≥ 60 years (male and female patients)
2. Ability to understand nature, risks, and benefits of study participation and to provide written informed consent.
3. Psychosocially, mentally, and physically capable of complying with all study requirements, including scheduled follow-up visits, completion of forms, and participation in all procedures as defined by the protocol.
4. Ambulatory prior to fracture, with or without the use of assistive devices

Fracture-related criteria:

1. Acute vertebral fractures located between T11 and L4 (inclusive)
2. Fractures deemed suitable for bisegmental hybrid stabilization based on clinical and radiological assessment - primarily OF type 3 and type 4 fractures according to DGOU classification; type 2 and 5 fractures may also be included based on individual evaluation, with the final treatment decision left to the discretion of the treating surgeon.

Exclusion Criteria:

Patient-related criteria:

1. Body mass index (BMI) \> 35
2. Permanent or progressive neurologic deficits (including upper motor neuron disease and myelopathy)
3. Rheumatoid arthritis or known disorders of bone metabolism (excluding osteopenia/osteoporosis, Vitamin D deficiency)
4. History of radiation therapy to the spine
5. History of alcohol or drug abuse within the last 2 years prior to randomization
6. Current therapy with high-dose systemic corticosteroids (e.g., \>10 mg/day prednisone equivalent for more than 3 months)
7. Ongoing or planned treatment with cytotoxic chemotherapy (excluding biologicals, immunotherapy, or targeted agents) at the time of enrollment
8. Known allergy to any component of the spinal instrumentation
9. Participation in other clinical investigations (drug or device) that may interfere with the outcomes of this study

Fracture-related criteria:

1. Vertebral fractures associated with neurological deficits
2. Fracture age \> 4 weeks at the time of enrollment
3. Pathological fractures due to spinal infection or metastatic bone disease
4. Planned major spinal surgery within 12 months of enrollment
5. Severe spinal deformities or fusion at the index or adjacent segments
6. Previous spinal surgery involving the index or adjacent vertebrae, with the exception of minor non-instrumented procedures, such as simple sequestrectomies or decompressions

Where it's running

  • Univ.-Klinik für Orthopädie und Traumatologie
    Innsbruck, Tyrol, Austria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.